Apr 21, 2025, 20:11

The NCI Transition Career Development Award

The NCI Transition Career Development Award (K22) provides support to mentored, non-independent cancer researchers who are ready to transition into independent, tenure-track faculty roles. The goal is to help promising investigators launch their careers in academic cancer research through a structured three-year award.

Eligibility Criteria

Must be a U.S. citizen, noncitizen national, or permanent resident at the time of award
Must be a clinical or research fellow in any area of cancer research
Must have between 2 and 8 years of mentored, non-independent research training post-terminal degree
Must not currently or previously hold a tenure-track faculty position or equivalent
Must not currently or previously hold an individual NIH career development award or equivalent
Must commit at least 9 person-months (75% full-time effort) to the K22 award

Funding Details

Duration: 3 years (non-renewable)
Salary support: Up to $100,000/year + fringe benefits
Research development support: Up to $50,000/year (includes technical support, consultant costs, supplies, travel, statistical support)
Indirect costs: 8%
No salary support allowed for mentors, admin assistants, or other ancillary staff

Key Deadlines

Application Receipt Cycles:
- Cycle 1: Feb 12 (new), Mar 12 (resubmission) – Start date: December
- Cycle 2: Jun 12 (new), Jul 12 (resubmission) – Start date: April
- Cycle 3: Oct 12 (new), Nov 12 (resubmission) – Start date: July
All applications due by 5 PM local time; deadlines extended to next business day if on a weekend/holiday

Further Information

For complete details and to apply, see the funding opportunity: PAR-24-117 (K22 Independent Clinical Trial Optional)

Questions? Contact the NCI program staff listed in the NOFO or consult the NCI Funding for Cancer Training FAQ

academic research careers cancer cancer research funding cancer training grants Early-career researchers faculty transition K22 Award National Cancer Institute NCI NIH K awards OncoDaily Oncology Research Fellowships Transition Career Development

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology

How Artificial Intelligence Is Transforming Cancer Care in 2025: Diagnosis, Treatment, Clinical Trials, and Screening

Inside ASCO25 Exhibition - Who did it the best?